| Miss Lindsay Nicole Belyea, CCC-SLP | |
|
7 Partridge Rd, Concord, NH 03301-7886 | |
| (860) 878-1219 | |
| (603) 898-4385 |
| Full Name | Miss Lindsay Nicole Belyea |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 7 Partridge Rd, Concord, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598280927 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1722 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Lindsay Nicole Belyea, CCC-SLP 7 Partridge Rd, Concord, NH 03301-7886 Ph: (860) 878-1219 | Miss Lindsay Nicole Belyea, CCC-SLP 7 Partridge Rd, Concord, NH 03301-7886 Ph: (860) 878-1219 |
News Archive
Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, announces its annual BioCap Conference, which will take place at the Hilton Hotel, Manchester on the 29th September 2014.
Keck Graduate Institute (KGI) Director of Research Angelika Niemz has been awarded a four-year, $3.6 million collaborative research grant from the National Institutes of Health (NIH).
Elderly people who have osteoporosis have a high risk of bone fractures and those who previously had a fracture are at an increased risk of having another. Vitamin D and calcium, alone or in combination, are often recommended for the prevention of osteoporotic fractures.
NUCRYST Pharmaceuticals, a developer and manufacturer of medical products that fight infection and inflammation, today announced that on September 15, 2009 it received notice from the Nasdaq Stock Market that it no longer complies with Nasdaq Marketplace Rule 5550(a)(2) because, for the previous 30 consecutive business days, the bid price of its common stock had closed below the minimum requirement of $1.00 per share.
A new study reveals an important and newly discovered pathway used by disease-causing bacteria to evade the host immune system and survive and grow within the very cells meant to destroy them. This discovery may lead to new treatments and vaccines for tuberculosis (TB) and certain other chronic bacterial and parasitic infections.
› Verified 7 days ago
Nicole Mcaree, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Pillsbury St Ste 404, Concord, NH 03301 Phone: 603-228-7827 | |
Ms. Laura A Darling, M.S.CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 22 Bridge St Ste 1a, Concord, NH 03301 Phone: 603-224-1551 Fax: 603-224-1330 | |
Christopher Paul Doherty, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 144 South St, Concord, NH 03301 Phone: 603-225-0862 | |
Patricia Morrell, SPEECH PATHOLOGIST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 152 South St, Concord, NH 03301 Phone: 603-225-0827 | |
Ms. Wanda Moulton Denoncour, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 40 Sewalls Falls Rd, Concord, NH 03301 Phone: 603-225-0853 | |
Mrs. Andrea Parker, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Fisherville Rd Unit 20, Concord, NH 03303 Phone: 603-410-7577 | |
Elizabeth Sirois, SLP-CFY/NH Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 239 Pleasant St, Pleasant View Center, Concord, NH 03301 Phone: 603-224-6561 |